That's just plain ignorant. 60 patients have been treated under "emergency indications". Their doctors have done everything they could to get them leronlimab. Basically, they were dying and out of options. I don't think treating dying patients can be considered cherry-picking. They may not be in the trials, but they do provide significant anecdotal data.
News 
Market Data 
Discover 
